Stockscreener 앱 받기
0.69%
전일 마감가:
$295.76
열려 있는:
$295.49
하루 거래량:
1.64M
Relative Volume:
0.69
시가총액:
$158.13B
수익:
$34.76B
순이익/손실:
$6.62B
주가수익비율:
24.02
EPS:
12.23
순현금흐름:
$10.61B
1주 성능:
-0.93%
1개월 성능:
-3.92%
6개월 성능:
-3.07%
1년 성능:
-9.49%
1일 변동 폭
$293.35
$297.89
1주일 범위
$292.11
$301.47
52주 변동 폭
$253.30
$339.17
암젠 Stock (AMGN) Company Profile
명칭
Amgen Inc
전화
(805)447-1000
주소
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
AMGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMGN
Amgen Inc
|
293.72 | 157.54B | 34.76B | 6.62B | 10.61B | 12.23 |
|
LLY
Lilly Eli Co
|
711.68 | 625.77B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
179.29 | 424.47B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
210.60 | 364.92B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
126.98 | 240.07B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
MRK
Merck Co Inc
|
87.37 | 210.36B | 63.43B | 16.42B | 14.72B | 6.49 |
암젠 Stock (AMGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-20 | 재개 | Guggenheim | Neutral |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Peer Perform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-10-17 | 개시 | Bernstein | Outperform |
| 2024-10-14 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-27 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-08-07 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-05-03 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2024-05-03 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-03-28 | 재개 | Raymond James | Mkt Perform |
| 2024-02-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | 업그레이드 | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-02 | 업그레이드 | Truist | Hold → Buy |
| 2023-10-20 | 재개 | JP Morgan | Neutral |
| 2023-10-17 | 재개 | Morgan Stanley | Equal-Weight |
| 2023-10-11 | 재개 | BofA Securities | Neutral |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2023-04-24 | 재확인 | Oppenheimer | Outperform |
| 2023-03-13 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | 재확인 | Truist | Buy |
| 2022-11-18 | 개시 | Credit Suisse | Underperform |
| 2022-10-31 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2022-10-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | 개시 | SVB Leerink | Mkt Perform |
| 2022-02-09 | 재확인 | Barclays | Equal Weight |
| 2022-02-09 | 재확인 | Jefferies | Buy |
| 2022-02-09 | 재확인 | Morgan Stanley | Equal-Weight |
| 2022-02-09 | 재확인 | Oppenheimer | Outperform |
| 2022-02-09 | 재확인 | Wells Fargo | Equal Weight |
| 2022-01-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-12-09 | 재개 | Wells Fargo | Equal Weight |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 개시 | BMO Capital Markets | Market Perform |
| 2021-09-23 | 다운그레이드 | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | 개시 | Daiwa Securities | Buy |
| 2020-10-28 | 개시 | UBS | Neutral |
| 2020-10-26 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | 업그레이드 | Truist | Hold → Buy |
| 2020-10-09 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | 다운그레이드 | Truist | Buy → Hold |
| 2020-10-08 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | 재개 | Guggenheim | Neutral |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-03-30 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | 개시 | Barclays | Equal Weight |
| 2020-01-31 | 다운그레이드 | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-17 | 재개 | Morgan Stanley | Overweight |
| 2019-11-12 | 개시 | SunTrust | Buy |
| 2019-11-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-08-19 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2019-05-23 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
암젠 주식(AMGN)의 최신 뉴스
FY2026 EPS Estimates for Amgen Boosted by Cantor Fitzgerald - MarketBeat
EverSource Wealth Advisors LLC Has $9.52 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Nations Financial Group Inc. IA ADV - MarketBeat
Amgen Inc. $AMGN is Sector Gamma AS's 5th Largest Position - MarketBeat
Amgen’s New Study on Tarlatamab and AB248: A Potential Game-Changer for Lung Cancer Treatment - TipRanks
Ex-Dividend Reminder: Amgen, U.S. Physical Therapy and Dynex Capital - Nasdaq
Amgen’s AMG-410 is pan-KRAS inhibitor - BioWorld MedTech
RWA Wealth Partners LLC Purchases 2,270 Shares of Amgen Inc. $AMGN - MarketBeat
Edgar Lomax Co. VA Sells 9,305 Shares of Amgen Inc. $AMGN - MarketBeat
Corient IA LLC Purchases New Holdings in Amgen Inc. $AMGN - MarketBeat
Brooklyn Investment Group Purchases 1,775 Shares of Amgen Inc. $AMGN - MarketBeat
Northern Trust Corp Lowers Stake in Amgen Inc. $AMGN - MarketBeat
Dimensional Fund Advisors LP Has $940.99 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Ethic Inc. - MarketBeat
3 Dow Jones Dividend Stocks With Above-Average Yields You Can Buy Now and Hold for at Least a Decade - The Motley Fool
Sei Investments Co. Purchases 4,282 Shares of Amgen Inc. $AMGN - MarketBeat
Waypoint Wealth Partners Inc. Purchases New Position in Amgen Inc. $AMGN - MarketBeat
Aberdeen Group plc Sells 126,680 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by American Investment Services Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Amgen Inc. $AMGN Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Freestone Capital Holdings LLC Has $3.63 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Seven Mile Advisory Acquires Shares of 891 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Steward Partners Investment Advisory LLC Has $23.04 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Cresset Asset Management LLC Decreases Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
How Amgen Inc. (AMGN) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Amgen: New Breakthroughs in Obesity, Rare Diseases, & High-Impact Therapies; But Is It Enough? - Smartkarma
FY2025 EPS Estimates for Amgen Lifted by Cantor Fitzgerald - MarketBeat
Rep. Lisa C. McClain Buys Amgen Inc. (NASDAQ:AMGN) Shares - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Stock Position Lifted by Raymond James Financial Inc. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Philadelphia Trust Co. - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Brandywine Global Investment Management LLC - MarketBeat
GKV Capital Management Co. Inc. Sells 10,745 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Boston Partners - MarketBeat
Sienna Gestion Decreases Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Lowers Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Bought by Rathbones Group PLC - MarketBeat
Tokio Marine Asset Management Co. Ltd. Acquires 990 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Can Amgen Inc. continue delivering strong returnsMarket Sentiment Report & Free Community Consensus Stock Picks - thegnnews.com
E Fund Management Co. Ltd. Has $6.03 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Prudential PLC Decreases Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
AIA Group Ltd Purchases Shares of 1,413 Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Precision Trading with Amgen Inc. (AMGN) Risk Zones - news.stocktradersdaily.com
Russell Investments Group Ltd. Reduces Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS - Benzinga
Amgen’s KRAS Mutation Study: A Potential Game-Changer in Colorectal Cancer Treatment - MSN
Amgen’s Evolocumab Study Completes: A New Era in Cardiovascular Prevention? - MSN
Amgen’s Promising Phase 2 Asthma Study: What Investors Need to Know - MSN
Amgen’s Sotorasib Study Update: Expanded Access for NSCLC Patients - MSN
Public Sector Pension Investment Board Purchases 5,732 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
암젠 (AMGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.54%
1.18%
자본화:
|
볼륨(24시간):